De Ambroggi L, Bertoni T, Marangoni E, Marconi M, Klersy C, Eriano G, Ambrosini F, Panciroli C, Salerno J A
G Ital Cardiol. 1987 Jan;17(1):63-72.
The electrocardiographic changes during and after the thrombolytic treatment with streptokinase (SK) were assessed by means of body surface potential mapping. The aim of the study was to identify potential patterns suggesting reperfusion and revealing possible short-term effects on the infarct size of the recanalization. We studied 23 patients enrolled in the G.I.S.S.I. trial; 11 had an anterior and 12 had an inferior myocardial infarction; 14 were treated with SK and 9 were controls. Body surface maps were recorded from 105 lead points located on the anterior thoracic surface using an automated instrument. The maps were obtained immediately before the SK infusion (or at the time of randomization in the control patients), 30, 60, 120 minutes thereafter and then 24 hours and 7 days after the onset of the infarct symptoms. In each patient the surface potential distribution at 100 msec after the end of QRS was considered and the sum of all the positive potential values was calculated (sigma ST). In addition, the potential time integrals relating to two intervals of the cardiac cycle (first 100 msec of ST and first 40 msec of QRS) were calculated at each lead point and transferred to diagrams representing the chest surface explored (isointegral map). With respect to Q-40 maps, deviation index maps were calculated as follows: the mean Q-40 map (obtained from 30 normal subjects) was subtracted from the map of each patient; the value obtained at each lead point was then divided by the standard deviation of the normal values for that point. An area where the integral values were at least 2 SD lower than normal was considered a reliable index of infarct. By considering as index of reperfusion an early peak of CPK (less than 12 hours from the onset of infarct symptoms), we divided the patients into 2 subsets: reperfused (R) and not reperfused (NR). The mean values of sigma ST at 100 msec progressively decreased in all patients from the baseline to the subsequent recordings in both control and SK groups, without significant differences; nevertheless, the highest percent reductions of sigma ST were observed only in some R patients. The maximum on the ST-100 isointegral maps also showed a similar behaviour.(ABSTRACT TRUNCATED AT 250 WORDS)
采用体表电位标测法评估了链激酶(SK)溶栓治疗期间及之后的心电图变化。本研究的目的是识别提示再灌注的潜在模式,并揭示再通对梗死面积可能产生的短期影响。我们研究了23例参与GISSI试验的患者;11例为前壁心肌梗死,12例为下壁心肌梗死;14例接受SK治疗,9例为对照。使用自动仪器从前胸表面的105个导联点记录体表电位图。在输注SK之前(或对照患者随机分组时)、之后30、60、120分钟,然后在梗死症状发作后24小时和7天获取电位图。在每位患者中,考虑QRS结束后100毫秒时的表面电位分布,并计算所有正电位值的总和(σST)。此外,在每个导联点计算与心动周期两个间期(ST段的前100毫秒和QRS波的前40毫秒)相关的电位时间积分,并将其转换为代表所探查胸壁表面的图表(等积分图)。对于Q - 40图,偏差指数图的计算方法如下:从每位患者的图中减去平均Q - 40图(由30名正常受试者获得);然后将每个导联点获得的值除以该点正常值的标准差。积分值至少比正常低2个标准差的区域被认为是梗死的可靠指标。通过将CPK早期峰值(梗死症状发作后少于12小时)视为再灌注指标,我们将患者分为2个亚组:再灌注(R)组和未再灌注(NR)组。在对照和SK组中,所有患者从基线到后续记录时,100毫秒时的σST平均值均逐渐下降,无显著差异;然而,仅在一些R组患者中观察到σST的最大百分比降低。ST - 100等积分图上的最大值也显示出类似的变化。(摘要截断于250字)